The European Brain Council is pleased to introduce the Seal of Responsible Neurotechnologies, a voluntary ethical label to address unmet governance needs in the neurotechnology sector.
Neurotechnologies, encompassing devices and procedures that interact with the brain and nervous system, are increasingly deployed outside clinical settings, raising ethical questions about human agency, mental privacy and freedom of thought that existing EU regulations do not comprehensively address. The Seal of Responsible Neurotechnologies fills this governance gap by establishing an independent ethical standard above minimum legal compliance, applicable to both medical, non-medical and research neurotechnologies.
The Seal is a mark of trust which does not replace existing regulatory approvals such as CE marking under the MDR, but complements them through a higher-level ethical and governance framework specific to neurotechnologies.
The Seal directly operationalises the principles set out in the European Charter for the Responsible Development of Neurotechnologies, anchored in the OECD Recommendation on Responsible Innovation in Neurotechnology (2019) and aligned with the UNESCO Recommendation on the Ethics of Neurotechnology (2025), with three core objectives:
✔️ Promoting responsible, human-centred and rights-oriented innovation and business conduct
✔️ Strengthening public trust, market integrity and regulatory stewardship
✔️ Providing a clear, recognisable signal of ethical commitment beyond minimum legal compliance
The pilot programme will launch shortly: a closed, pre-launch phase involving a carefully selected group of organisations. Its purpose is to test and refine the accreditation criteria, application procedure and assessment methodology before the Seal is formally launched.
Its launch is timely: the EU AI Act has entered enforcement, investor scrutiny of neurotechnology ethics continues to intensify and – as CFG‘s white paper “Towards an EU Neurotechnology Strategy” makes clear – Europe still lacks a joined-up framework capable of aligning innovation, rights protection and public trust in this field. The Seal is designed to fill that gap and to serve as a practical governance reference that an EU Neurotech Strategy can build upon. By offering a single, coherent ethical framework layered across existing EU instruments, the Seal simplifies the compliance landscape for neurotechnology actors.
EBC’s multi-stakeholder composition positions it as a credible steward of this initiative, bringing together scientific, clinical, patient and industry perspectives at the interface of science, policy and society.
Further details on the Seal and application process will be shared soon. Subscribe to the newsletter to stay updated!